Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

α-Asarocyl alcohol and its preparation method and application

A technology of asaranol and fatty alcohol, applied in the field of preparation of alpha-asaranol, can solve problems such as cognitive dysfunction, severe allergic reaction and the like

Active Publication Date: 2016-11-02
NORTHWEST UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the second-generation antiepileptic drugs have partially improved the shortcomings of the first-generation drugs, most of the second-generation drugs can still be accompanied by some specific adverse reactions, such as cognitive dysfunction, acute eye symptoms, severe allergic reactions, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • α-Asarocyl alcohol and its preparation method and application
  • α-Asarocyl alcohol and its preparation method and application
  • α-Asarocyl alcohol and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Preparation of Methyl 2,4,5-Trimethoxycinnamate

[0022] A 3L three-necked flask with a thermometer and a condenser tube was added with 195.5g (1.35mol) of McFarlandic acid (1.35mol), methanol (50mL) and toluene (750mL), heated to reflux at 110°C for 4 hours, cooled to room temperature, and then added with 2,4 , 196.2g (1.0mol) of 5-trimethoxybenzaldehyde, 134.5g (1.7mol) of pyridine, and 14.5g (0.17mol) of piperidine, heated to reflux for 18 hours, concentrated under reduced pressure, then added ethyl acetate (200mL), Water (200mL), extracted and separated 3 times, combined the organic phases, concentrated under reduced pressure, added ethanol (1000mL), refrigerated overnight in the refrigerator, after the precipitation was precipitated, filtered with suction, washed 3 times with 500mL of ice ethanol to obtain a light yellow solid 166.3 g, 66% yield.

[0023] m / z=[M+1]253.1086

[0024] 1 H NMR (600MHz, cdcl3) δ7.97(d, J=16.1Hz, 1H), 7.01(s, 1H), 6.50(s, 1H), 6.38(d,...

Embodiment 2

[0027] Preparation of ethyl 2,4,5-trimethoxycinnamate

[0028] In a 250mL three-neck flask with a thermometer and a condenser tube, add 20.2g (0.14mol) of McFarlandic acid (0.14mol), ethanol (10mL), and toluene (150mL) respectively, heat and reflux at 110°C for 4 hours, cool to room temperature, and then add 2,4 , 19.6g (0.1mol) of 5-trimethoxybenzaldehyde, 13.5g (0.17mol) of pyridine, and 1.5g (0.017mol) of piperidine, heated to reflux for 18 hours, concentrated under reduced pressure, then added ethyl acetate (50mL), Water (50mL), extracted and separated 3 times, combined the organic phases, concentrated under reduced pressure, added ethanol (150mL), refrigerated overnight, after the precipitate was precipitated, filtered with suction, washed 3 times with 100mL ice-ethanol to obtain a light yellow solid 16.0 g, 60% yield.

Embodiment 3

[0030] Preparation of Propyl 2,4,5-Trimethoxycinnamate

[0031] In a 250mL three-neck flask with a thermometer and a condenser tube, add 10.1g (70mmol) of McBurney's acid, propanol (8mL), and toluene (80mL) respectively, heat and reflux at 110°C for 4 hours, cool to room temperature, and then add 2,4 , 5-trimethoxybenzaldehyde 9.8g (50mmol), pyridine 6.7g (85mmol), piperidine 0.75g (8.5mmol), heated to reflux for 18 hours, concentrated under reduced pressure, added ethyl acetate (20mL), water ( 30mL), extracted and separated 3 times, combined the organic phases, concentrated under reduced pressure, added ethanol (80mL), refrigerated overnight in the refrigerator, after the precipitation was precipitated, filtered with suction, washed 3 times with 50mL of ice ethanol, and obtained 7.7g of light yellow solid , yield 55%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to α-asarol and its preparation method and application. The α-asarol involved is of structural formula I. The preparation method involves decarboxylation of 2,4,5-trimethoxybenzaldehyde and isopropylidene malonate (meldrum's acid) and fatty alcohol under the catalysis of pyridine and piperidine to obtain trans 2, 4,5-trimethoxycinnamate is then reduced with a reducing agent to obtain α-asarol. The preparation method of the invention is simple and has high yield. The application involved is the use of α-asarol in the preparation of sedative, tranquilizing, anti-Alzheimer's, anticonvulsant, anti-epileptic or cardiovascular and cerebrovascular protection drugs.

Description

technical field [0001] The invention mainly relates to a preparation method and application of α-asaroctanol, and belongs to the field of medicine synthesis and medicine technology. Background technique [0002] The International League Against Epilepsy defines epilepsy as a brain disorder characterized by the persistence of persistent changes in the brain that can produce seizures, with corresponding neurobiological, cognitive, psychological, and sociological consequences. Epilepsy patients account for 1-2% of the world's population [White H.S. Epilepsia. 2003, 44, 2]. [0003] Phenobarbital, phenytoin, and carbamazepine are first-generation antiepileptic drugs. In contrast, levetiracetam, oxcarbazepine, rufinamide, etc., as second-generation antiepileptic drugs, have the advantages of good pharmacokinetics, low toxicity, safety, and high efficiency [Prunetti P.Curr.Opin.Neurol .2011, 24, 159]. Although the second-generation antiepileptic drugs have partially improved t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C43/23C07C41/26A61P25/20A61P25/28A61P25/08A61P9/00
Inventor 郑晓晖白亚军秦方刚王世祥张毅刘佩何希瑞
Owner NORTHWEST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products